Reply to Khoruts and Sadowsky

Sahil Khanna; Raseen Tariq; Darrell S. Pardi

doi:10.1093/cid/ciz367

Reply to Khoruts and Sadowsky

Sahil Khanna, Raseen Tariq, Darrell S. Pardi

Gastroenterology and Hepatology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2233-2234
Number of pages	2
Journal	Clinical Infectious Diseases
Volume	69
Issue number	12
DOIs	https://doi.org/10.1093/cid/ciz367
State	Published - Nov 27 2019

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciz367

Cite this

@article{0f19e0519aca442eb83c592fddd8676d,

title = "Reply to Khoruts and Sadowsky",

author = "Sahil Khanna and Raseen Tariq and Pardi, {Darrell S.}",

note = "Funding Information: a consultant for Shire Plc, Probiotech LLC, Facile Therapeutics, and Premier Inc and received research support from Rebiotix Inc. outside the submitted work. D. S. P. has served as a consultant for Merck, C3Jain Therapeutics, Nestl{\'e}, and Salix Pharmaceuticals and received research support from Seres Therapeutics outside the submitted work. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.",

year = "2019",

month = nov,

day = "27",

doi = "10.1093/cid/ciz367",

language = "English (US)",

volume = "69",

pages = "2233--2234",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Reply to Khoruts and Sadowsky

AU - Khanna, Sahil

AU - Tariq, Raseen

AU - Pardi, Darrell S.

N1 - Funding Information: a consultant for Shire Plc, Probiotech LLC, Facile Therapeutics, and Premier Inc and received research support from Rebiotix Inc. outside the submitted work. D. S. P. has served as a consultant for Merck, C3Jain Therapeutics, Nestlé, and Salix Pharmaceuticals and received research support from Seres Therapeutics outside the submitted work. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

PY - 2019/11/27

Y1 - 2019/11/27

UR - http://www.scopus.com/inward/record.url?scp=85075805296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075805296&partnerID=8YFLogxK

U2 - 10.1093/cid/ciz367

DO - 10.1093/cid/ciz367

M3 - Letter

C2 - 31051032

AN - SCOPUS:85075805296

SN - 1058-4838

VL - 69

SP - 2233

EP - 2234

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 12

ER -

Reply to Khoruts and Sadowsky

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this